271 related articles for article (PubMed ID: 6814466)
1. [Controlled clinical trial of dihydroergocristine in neuropsychiatric disorders in cerebrovascular insufficiency].
Muchnik S
Boll Chim Farm; 1982 May; 121(5):33S-46S. PubMed ID: 6814466
[No Abstract] [Full Text] [Related]
2. [Controlled clinical study of use of dihydroergocristine in cerebral and periferal vascular disorders].
Calisti G; Biscarini L; Miseo A
Clin Ter; 1977 Nov; 83(4):371-86. PubMed ID: 414875
[No Abstract] [Full Text] [Related]
3. [Clinical trials with dihydroergocristine in patients with vascular and cerebral insufficiency].
Ingelmo M; Vivancos J; Peri J; Balcells Gorina A
Rev Clin Esp; 1980 Dec; 159(6):399-402. PubMed ID: 6784197
[No Abstract] [Full Text] [Related]
4. [Multi-center clinical study of the effects of a vasoregulatory-eumetabolic drug (vincamine hydrochloride) on the psychological symptoms of cerebrovascular insufficiency].
Periti P; Periti G; Colombo Pirola L
Clin Ter; 1981 Apr; 97(2):137-45. PubMed ID: 7016415
[No Abstract] [Full Text] [Related]
5. [Card-Hydergin for treatment of heart insufficiency in elderly patients with cerebrovascular deficiency].
Schmidt W
ZFA (Stuttgart); 1977 Mar; 53(8):447-52. PubMed ID: 324165
[No Abstract] [Full Text] [Related]
6. [Experiences with Card-hydergine in patients with cardiac insufficiency and cerebrovascular disorders in professional practice].
Kohler H
Med Monatsschr; 1976 Nov; 30(11):516-8. PubMed ID: 792670
[No Abstract] [Full Text] [Related]
7. Neuropsychological deficits in right hemisphere stroke patients. I: Methods and results from factor analysis.
Finset A
J Oslo City Hosp; 1988; 38(8-9):77-83. PubMed ID: 3241286
[No Abstract] [Full Text] [Related]
8. [Treatment of organic brain psychosyndrom in the old age. A double blind study with Hydergin (author's transl)].
Biel ML; Seus R; Struppler A
Med Klin; 1976 Dec; 71(49):2177-84. PubMed ID: 794665
[TBL] [Abstract][Full Text] [Related]
9. [Treatment of cerebrovascular insufficiency].
Cosentino F; Baldassarri R
Clin Ter; 1979 Mar; 88(6):631-8. PubMed ID: 380878
[No Abstract] [Full Text] [Related]
10. [Trials in the treatment of cerebrovascular insufficiency with the monodrug dihydroergocristine. A multicentric study].
Finke J; Haehn KD; Haase W
Med Welt; 1982 Jul; 33(28):1042-7. PubMed ID: 6811832
[No Abstract] [Full Text] [Related]
11. [Therapy of chronic cerebrovascular insufficiency. Controlled comparative study of 2 cerebral antihypoxidosis agents].
Szobor A; Klein M; Bräuer H
MMW Munch Med Wochenschr; 1982 Oct; 124(41):897-900. PubMed ID: 6815511
[No Abstract] [Full Text] [Related]
12. [Controlled clinical study and clinico-psychological evaluation of a preparation with neurotrophic effects].
Montini M; Ongaro A; Simonutti M
Clin Ter; 1977 Aug; 82(3):243-62. PubMed ID: 334449
[No Abstract] [Full Text] [Related]
13. DH Ergotoxin (Spofa) sublingual tablets in the treatment of cerebrovascular insufficiency in involution: clinical and experimental psychologic study.
Misurec J; Morávek Z; Náhunek K; Cesková E; Sláma B; Svestka J
Act Nerv Super (Praha); 1978 Dec; 20(4):266-7. PubMed ID: 367038
[No Abstract] [Full Text] [Related]
14. [Controlled clinical study on the activity and tolerance of Trivastan].
Nicrosini F; Pasotti C
Minerva Med; 1976 May; 67(26):1745-50. PubMed ID: 778674
[No Abstract] [Full Text] [Related]
15. The objective measurement of mental performance in cerebrovascular disease. A double-blind controlled study, using a graded-release preparation of isoxsuprine.
Hussain SM; Gedye JL; Naylor R; Brown AL
Practitioner; 1976 Feb; 216(1292):222-8. PubMed ID: 772660
[TBL] [Abstract][Full Text] [Related]
16. Valproate use in neuropsychiatric disorders in the elderly.
Tariot PN
Psychopharmacol Bull; 2003; 37 Suppl 2():116-28. PubMed ID: 15021866
[TBL] [Abstract][Full Text] [Related]
17. [Therapeutic effectiveness and safety of dihydroergocristine. A study of 9,702 patients].
Mailland F; Zottino G
Fortschr Med; 1986 Mar; 104(11):239-42. PubMed ID: 3084366
[No Abstract] [Full Text] [Related]
18. Relieving select symptoms of the elderly.
Nelson JJ
Geriatrics; 1975 Mar; 30(3):133-9, 142. PubMed ID: 803912
[No Abstract] [Full Text] [Related]
19. Caution on the potential usefulness of statins in neuropsychiatric diseases.
Brondino N; Emanuele E; Geroldi D
Med Hypotheses; 2007; 69(3):697. PubMed ID: 17350766
[No Abstract] [Full Text] [Related]
20. [Treatment of cerebral wasting diseases with Card-Hydergin].
Liebhart M
Med Welt; 1976 Nov; 76(48):2341-6. PubMed ID: 794620
[No Abstract] [Full Text] [Related]
[Next] [New Search]